Neutropenia Information Center
A low white blood cell count or “neutropenia” is a condition characterized by abnormally low levels of neutrophils in the circulating blood. Neutrophils are a specific kind of white blood cell that help prevent and fight infections. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy. Chemotherapy-induced neutropenia increases a patient’s risk of infection and disrupts cancer treatment. Fortunately, neutropenia can be prevented through the use of white blood cell growth factors. The prevention of neutropenia allows patients to receive their scheduled treatment and reduces the risk of infection and hospitalization.
Headline Neutropenia News 
Dose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma
Relative dose intensity (RDI) remains a key factor in the outcomes of patients with...
Neulasta® Deemed Cost-effective for Prevention of Febrile Neutropenia in Breast Cancer Patients
The prophylactic use of Neulasta® (pegfilgrastim) is cost-effective for the prevention...
Early Use of Neulasta® Superior to Later Use In Elderly Patients Undergoing Chemotherapy
The use of Neulasta® (pegfilgrastim) after the first cycle of chemotherapy among...
Neutropenia In Depth
Conquering Chemotherapy-How advances in the management of neutropenia have led to advances in curative therapy.
If you were to ask the average person—even the most health conscious of your friends—what their neutrophil count is...
Successful Treatment Means Staying on Schedule
In order to receive the best possible benefit from your cancer therapy, it is important...
Neutropenia Management
Neutropenia Tips
Many cancer patients are at an increased risk of infection because of their low levels...
Most patients would prefer to prevent infection rather than having to deal with its...
In order to receive the best possible benefit from your cancer therapy, it is important...



